Bruce D. Weintraub
Directeur Général chez Trophogen, Inc.
Profil
Bruce D.
Weintraub is the founder of Trophogen, Inc. which was founded in 2001.
He currently holds the title of President & Chief Executive Officer at Trophogen, Inc. Dr. Weintraub's former job positions include being an Assistant Professor at Harvard University, a Professor at the University of Maryland from 1996 to 2001, and a Member at The Endocrine Society.
In terms of education, Dr. Weintraub holds a doctorate degree from Harvard University and an undergraduate degree from Princeton University.
Postes actifs de Bruce D. Weintraub
Sociétés | Poste | Début |
---|---|---|
Trophogen, Inc.
Trophogen, Inc. BiotechnologyHealth Technology Trophogen, Inc. develops glycoprotein hormones and therapeutic applications. The firm's research is focused on developing super-agonists and antagonists of cystine knot growth factors and therapy and imaging of thyroid, ovarian, breast, prostate and testicular cancers. The company was founded by Bruce D. Weintraub and Mariusz W. Szkudlinski in July 2001 and is headquartered in Rockville, MD. | Directeur Général | 01/07/2001 |
Anciens postes connus de Bruce D. Weintraub
Sociétés | Poste | Fin |
---|---|---|
University of Maryland | Corporate Officer/Principal | 01/01/2001 |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
The Endocrine Society | Corporate Officer/Principal | - |
Formation de Bruce D. Weintraub
Harvard University | Doctorate Degree |
Princeton University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Trophogen, Inc.
Trophogen, Inc. BiotechnologyHealth Technology Trophogen, Inc. develops glycoprotein hormones and therapeutic applications. The firm's research is focused on developing super-agonists and antagonists of cystine knot growth factors and therapy and imaging of thyroid, ovarian, breast, prostate and testicular cancers. The company was founded by Bruce D. Weintraub and Mariusz W. Szkudlinski in July 2001 and is headquartered in Rockville, MD. | Health Technology |
The Endocrine Society |